Scott E Smith Selected Research

Scott E Smith Research Topics

Disease

6	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 06/2012
5	Lymphoma (Lymphomas) 04/2024 - 06/2012
4	Neoplasms (Cancer) 04/2024 - 10/2003
4	Hematologic Neoplasms (Hematological Malignancy) 04/2017 - 04/2012
3	Multiple Myeloma 12/2020 - 01/2016
3	Neutropenia 09/2017 - 10/2003
2	Infections 10/2021 - 04/2017
2	Disease Progression 12/2018 - 09/2017
2	Thrombocytopenia (Thrombopenia) 09/2017 - 04/2012
2	Exanthema (Rash) 04/2017 - 11/2016
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2017 - 11/2016
2	Nausea 01/2013 - 04/2012
2	Vomiting 01/2013 - 04/2012
2	Fatigue 04/2012 - 01/2006
1	Hypertension (High Blood Pressure) 10/2021
1	Atrial Fibrillation 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2017
1	Clostridium Infections 04/2017
1	Fever (Fevers) 04/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2017
1	Hypotension (Low Blood Pressure) 04/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2014
1	Leukemia 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2012
1	Diarrhea 04/2012
1	Anorexia 04/2012
1	Anemia 04/2012
1	Headache (Headaches) 01/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2006
1	Dyspnea (Shortness of Breath) 01/2006

Drug/Important Bio-Agent (IBA)

7	Brentuximab VedotinIBA 01/2016 - 06/2012
5	Rituximab (Mabthera)FDA Link 12/2018 - 01/2016
4	Lenalidomide (CC 5013)FDA Link 09/2017 - 04/2012
3	ibrutinibIBA 10/2021 - 11/2016
2	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 01/2016
2	Bortezomib (Velcade)FDA Link 12/2020 - 01/2016
2	Busulfan (Busulfex)FDA Link 12/2020 - 01/2016
1	pembrolizumabIBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	IceIBA 01/2023
1	Ifosfamide FDA LinkGeneric 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Bendamustine Hydrochloride FDA Link 12/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2017
1	Cytotoxins (Cytolysins)IBA 04/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017
1	Alanine Transaminase (SGPT)IBA 04/2017
1	idelalisibIBA 04/2017
1	Vincristine (Oncovin)FDA LinkGeneric 11/2016
1	Adenosine Monophosphate (AMP)IBA 11/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2016
1	Prednisone (Sone)FDA LinkGeneric 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016
1	SurvivinIBA 01/2016
1	sepantroniumIBA 01/2016
1	Immunoconjugates (Immunoconjugate)IBA 02/2015
1	AZD 6244IBA 01/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014
1	AntiemeticsIBA 01/2013
1	Ondansetron (Zofran)FDA LinkGeneric 01/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Aprepitant (Emend)FDA Link 01/2013
1	EmeticsIBA 01/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2012
1	Hemoglobins (Hemoglobin)IBA 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2003

Therapy/Procedure

7	Stem Cell Transplantation 04/2024 - 01/2006
6	Therapeutics 04/2024 - 10/2003
3	Hematopoietic Stem Cell Transplantation 12/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
1	Radiotherapy 04/2024
1	Salvage Therapy 01/2023
1	Drug Tapering 11/2016
1	Retreatment 03/2014
1	Transplantation 01/2013